Pan-cancer analysis reveals the potential of hyaluronate synthase as therapeutic targets in human tumors.

Bao, Xunxia; Ran, Juan; Kong, Chuifang; Wan, Zunxi; Wang, Juling; Yu, Tengfei; Ruan, Shengming; Ding, Wenjing; Xia, Leiming; Zhang, Daoxiang

Bao, Xunxia; Ran, Juan; Kong, Chuifang; Wan, Zunxi; Wang, Juling; Yu, Tengfei; Ruan, Shengming; Ding, Wenjing; Xia, Leiming; Zhang, Daoxiang.

Afiliación

Bao X; School of Life Sciences, Anhui Medical University, Hefei, 230032, China.
Ran J; School of Life Sciences, Anhui Medical University, Hefei, 230032, China.
Kong C; School of Life Sciences, Anhui Medical University, Hefei, 230032, China.
Wan Z; School of Life Sciences, Northeast Normal University, Changchun, 130024, China.
Wang J; School of Life Sciences, Anhui Medical University, Hefei, 230032, China.
Yu T; School of Life Sciences, Anhui Medical University, Hefei, 230032, China.
Ruan S; School of Life Sciences, Anhui Medical University, Hefei, 230032, China.
Ding W; School of Life Sciences, Anhui Medical University, Hefei, 230032, China.
Xia L; Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Zhang D; School of Life Sciences, Anhui Medical University, Hefei, 230032, China.

Heliyon ; 9(8): e19112, 2023 Aug.

Article en En | MEDLINE | ID: mdl-37636435

Palabras clave

Extracellular matrix; Glioblastoma multiforme; Hyaluronate synthase; Immune; Pan-cancer; Prognosis; Tumor microenvironment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Heliyon Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google